5oqv › Citations

Fibril structure of amyloid-β(1-42) by cryo-electron microscopy.

Gremer L, Schölzel D, Schenk C, Reinartz E, Labahn J, Ravelli RBG, Tusche M, Lopez-Iglesias C, Hoyer W, Heise H, Willbold D, Schröder GF
Science 358 116-119 (2017)
Cited: 381 times
EuropePMC logo PMID: 28882996

Abstract

Amyloids are implicated in neurodegenerative diseases. Fibrillar aggregates of the amyloid-β protein (Aβ) are the main component of the senile plaques found in brains of Alzheimer's disease patients. We present the structure of an Aβ(1-42) fibril composed of two intertwined protofilaments determined by cryo-electron microscopy (cryo-EM) to 4.0-angstrom resolution, complemented by solid-state nuclear magnetic resonance experiments. The backbone of all 42 residues and nearly all side chains are well resolved in the EM density map, including the entire N terminus, which is part of the cross-β structure resulting in an overall "LS"-shaped topology of individual subunits. The dimer interface protects the hydrophobic C termini from the solvent. The characteristic staggering of the nonplanar subunits results in markedly different fibril ends, termed "groove" and "ridge," leading to different binding pathways on both fibril ends, which has implications for fibril growth.

Reviews - 5oqv mentioned but not cited (18)

  1. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis. Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, Dominguez L, Shea JE, Dokholyan NV, De Simone A, Ma B, Nussinov R, Najafi S, Ngo ST, Loquet A, Chiricotto M, Ganguly P, McCarty J, Li MS, Hall C, Wang Y, Miller Y, Melchionna S, Habenstein B, Timr S, Chen J, Hnath B, Strodel B, Kayed R, Lesné S, Wei G, Sterpone F, Doig AJ, Derreumaux P. Chem Rev 121 2545-2647 (2021)
  2. Amyloid-Like Aggregation in Diseases and Biomaterials: Osmosis of Structural Information. Balasco N, Diaferia C, Morelli G, Vitagliano L, Accardo A. Front Bioeng Biotechnol 9 641372 (2021)
  3. Defining the Landscape of the Pauling-Corey Rippled Sheet: An Orphaned Motif Finding New Homes. Raskatov JA, Schneider JP, Nilsson BL. Acc Chem Res 54 2488-2501 (2021)
  4. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates. Creekmore BC, Chang YW, Lee EB. J Neuropathol Exp Neurol 80 514-529 (2021)
  5. Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease. Roda AR, Serra-Mir G, Montoliu-Gaya L, Tiessler L, Villegas S. Neural Regen Res 17 1666-1674 (2022)
  6. Catalytically-active inclusion bodies for biotechnology-general concepts, optimization, and application. Jäger VD, Lamm R, Küsters K, Ölçücü G, Oldiges M, Jaeger KE, Büchs J, Krauss U. Appl Microbiol Biotechnol 104 7313-7329 (2020)
  7. Coiled-Coil Based Inclusion Bodies and Their Potential Applications. Gil-Garcia M, Ventura S. Front Bioeng Biotechnol 9 734068 (2021)
  8. Comparing the Folds of Prions and Other Pathogenic Amyloids. Flores-Fernández JM, Rathod V, Wille H. Pathogens 7 (2018)
  9. Amyloid Disassembly: What Can We Learn from Chaperones? Almeida ZL, Brito RMM. Biomedicines 10 3276 (2022)
  10. Catalytically Active Amyloids as Future Bionanomaterials. Diaz-Espinoza R. Nanomaterials (Basel) 12 3802 (2022)
  11. Conformational Variability of Amyloid-β and the Morphological Diversity of Its Aggregates. Yagi-Utsumi M, Kato K. Molecules 27 4787 (2022)
  12. Interpretable artificial intelligence and exascale molecular dynamics simulations to reveal kinetics: Applications to Alzheimer's disease. Martin W, Sheynkman G, Lightstone FC, Nussinov R, Cheng F. Curr Opin Struct Biol 72 103-113 (2022)
  13. Passive immunotherapies targeting Aβ and tau in Alzheimer's disease. Plotkin SS, Cashman NR. Neurobiol Dis 144 105010 (2020)
  14. Recent High-Resolution Structures of Amyloids Involved in Neurodegenerative Diseases. Diaz-Espinoza R. Front Aging Neurosci 13 782617 (2021)
  15. Structural biology of cell surface receptors implicated in Alzheimer's disease. Hermans SJ, Nero TL, Morton CJ, Gooi JH, Crespi GAN, Hancock NC, Gao C, Ishii K, Markulić J, Parker MW. Biophys Rev 14 233-255 (2022)
  16. Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts. Al Adem K, Lee S. Protein Sci 32 e4639 (2023)
  17. The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation. Galzitskaya OV, Grishin SY, Glyakina AV, Dovidchenko NV, Konstantinova AV, Kravchenko SV, Surin AK. Int J Mol Sci 24 3781 (2023)
  18. The association of lipids with amyloid fibrils. Sanderson JM. J Biol Chem 298 102108 (2022)

Articles - 5oqv mentioned but not cited (61)

  1. Fibril structure of amyloid-β(1-42) by cryo-electron microscopy. Gremer L, Schölzel D, Schenk C, Reinartz E, Labahn J, Ravelli RBG, Tusche M, Lopez-Iglesias C, Hoyer W, Heise H, Willbold D, Schröder GF. Science 358 116-119 (2017)
  2. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. Nat Struct Mol Biol 27 653-659 (2020)
  3. Peptide-Based Vaccines: Current Progress and Future Challenges. Malonis RJ, Lai JR, Vergnolle O. Chem Rev 120 3210-3229 (2020)
  4. Sensitivity-Enhanced Solid-State NMR Detection of Structural Differences and Unique Polymorphs in Pico- to Nanomolar Amounts of Brain-Derived and Synthetic 42-Residue Amyloid-β Fibrils. Wickramasinghe A, Xiao Y, Kobayashi N, Wang S, Scherpelz KP, Yamazaki T, Meredith SC, Ishii Y. J Am Chem Soc 143 11462-11472 (2021)
  5. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations. Seuma M, Faure AJ, Badia M, Lehner B, Bolognesi B. Elife 10 e63364 (2021)
  6. Human Plasma Protein Corona of Aβ Amyloid and Its Impact on Islet Amyloid Polypeptide Cross-Seeding. Nandakumar A, Xing Y, Aranha RR, Faridi A, Kakinen A, Javed I, Koppel K, Pilkington EH, Purcell AW, Davis TP, Faridi P, Ding F, Ke PC. Biomacromolecules 21 988-998 (2020)
  7. Ultrasmall Molybdenum Disulfide Quantum Dots Cage Alzheimer's Amyloid Beta to Restore Membrane Fluidity. Li Y, Tang H, Zhu H, Kakinen A, Wang D, Andrikopoulos N, Sun Y, Nandakumar A, Kwak E, Davis TP, Leong DT, Ding F, Ke PC. ACS Appl Mater Interfaces 13 29936-29948 (2021)
  8. Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ42 Oligomers. Sun L, Sharma AK, Han BH, Mirica LM. ACS Chem Neurosci 11 2741-2752 (2020)
  9. The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Iadanza MG, Silvers R, Boardman J, Smith HI, Karamanos TK, Debelouchina GT, Su Y, Griffin RG, Ranson NA, Radford SE. Nat Commun 9 4517 (2018)
  10. Cryo-EM structures of amyloid-β 42 filaments from human brains. Yang Y, Arseni D, Zhang W, Huang M, Lövestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J, Lavenir I, Garringer HJ, Gelpi E, Newell KL, Kovacs GG, Vidal R, Ghetti B, Ryskeldi-Falcon B, Scheres SHW, Goedert M. Science 375 167-172 (2022)
  11. Differentiating Aβ40 and Aβ42 in amyloid plaques with a small molecule fluorescence probe. Yang J, Zhu B, Yin W, Han Z, Zheng C, Wang P, Ran C. Chem Sci 11 5238-5245 (2020)
  12. Kinetics and mechanical stability of the fibril state control fibril formation time of polypeptide chains: A computational study. Kouza M, Co NT, Li MS, Kmiecik S, Kolinski A, Kloczkowski A, Buhimschi IA. J Chem Phys 148 215106 (2018)
  13. Nanomechanical Stability of Aβ Tetramers and Fibril-like Structures: Molecular Dynamics Simulations. Poma AB, Thu TTM, Tri LTM, Nguyen HL, Li MS. J Phys Chem B 125 7628-7637 (2021)
  14. Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue. Chen Y, Wei G, Zhao J, Nussinov R, Ma B. ACS Chem Neurosci 11 3233-3244 (2020)
  15. Interactions between Curcumin Derivatives and Amyloid-β Fibrils: Insights from Molecular Dynamics Simulations. Jakubowski JM, Orr AA, Le DA, Tamamis P. J Chem Inf Model 60 289-305 (2020)
  16. Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress β-amyloid aggregation and neuronal toxicity. Anand BG, Wu Q, Karthivashan G, Shejale KP, Amidian S, Wille H, Kar S. Bioact Mater 6 4491-4505 (2021)
  17. Modification of amyloid-beta peptide aggregation via photoactivation of strained Ru(ii) polypyridyl complexes. Bataglioli JC, Gomes LMF, Maunoir C, Smith JR, Cole HD, McCain J, Sainuddin T, Cameron CG, McFarland SA, Storr T. Chem Sci 12 7510-7520 (2021)
  18. Protein Amyloid Cofactors: Charged Side-Chain Arrays Meet Their Match? Lewkowicz E, Jayaraman S, Gursky O. Trends Biochem Sci 46 626-629 (2021)
  19. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease. Horsley JR, Jovcevski B, Wegener KL, Yu J, Pukala TL, Abell AD. Biochem J 477 2039-2054 (2020)
  20. Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo. Yang J, Yin W, Van R, Yin K, Wang P, Zheng C, Zhu B, Ran K, Zhang C, Kumar M, Shao Y, Ran C. Nat Commun 11 4052 (2020)
  21. Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations. Muvva C, Murugan NA, Subramanian V. Int J Mol Sci 22 3244 (2021)
  22. Graphene quantum dots obstruct the membrane axis of Alzheimer's amyloid beta. Tang H, Li Y, Kakinen A, Andrikopoulos N, Sun Y, Kwak E, Davis TP, Ding F, Ke PC. Phys Chem Chem Phys 24 86-97 (2021)
  23. Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue. Bashit AA, Nepal P, Connors T, Oakley DH, Hyman BT, Yang L, Makowski L. Front Neurosci 16 909542 (2022)
  24. Mechanical and thermodynamic properties of Aβ42, Aβ40, and α-synuclein fibrils: a coarse-grained method to complement experimental studies. Poma AB, Guzman HV, Li MS, Theodorakis PE. Beilstein J Nanotechnol 10 500-513 (2019)
  25. Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers. Lieblein T, Zangl R, Martin J, Hoffmann J, Hutchison MJ, Stark T, Stirnal E, Schrader T, Schwalbe H, Morgner N. Elife 9 e59306 (2020)
  26. Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation. Lu J, Cao Q, Wang C, Zheng J, Luo F, Xie J, Li Y, Ma X, He L, Eisenberg D, Nowick J, Jiang L, Li D. Front Mol Neurosci 12 54 (2019)
  27. A DFT-Assisted Topological Analysis of Four Polymorphic, S-Shaped Aβ42 Fibril Structures. Foley AR, Raskatov JA. Chembiochem 20 1722-1724 (2019)
  28. A Molecular Integrative Study on the Inhibitory Effects of WRR and ERW on Amyloid β Peptide (1-42) Polymerization and Cell Toxicity. Wu Z, Ye L, Yuan N, Che Ajuyo NM, Xiao Z, Liu L, Chen Z, Pei Y, Min Y, Wang D. Polymers (Basel) 15 4356 (2023)
  29. A computational study of metal ions interaction with amyloid-β 1-42 peptide structure in hyperpyrexia: Implications for Alzheimer disease. Mocanu CS, Darie-Ion L, Petre BA, Gradinaru VR, Drochioiu G. J King Saud Univ Sci 34 102184 (2022)
  30. A lowly populated, transient β-sheet structure in monomeric Aβ1-42 identified by multinuclear NMR of chemical denaturation. Kakeshpour T, Ramanujam V, Barnes CA, Shen Y, Ying J, Bax A. Biophys Chem 270 106531 (2021)
  31. Amphiphilic stilbene derivatives attenuate the neurotoxicity of soluble Aβ42 oligomers by controlling their interactions with cell membranes. Yu Z, Guo W, Patel S, Cho HJ, Sun L, Mirica LM. Chem Sci 13 12818-12830 (2022)
  32. Amyloid-β Tetramers and Divalent Cations at the Membrane/Water Interface: Simple Models Support a Functional Role. Krupa P, La Penna G, Li MS. Int J Mol Sci 24 12698 (2023)
  33. Atomic Resolution Insights into pH Shift Induced Deprotonation Events in LS-Shaped Aβ(1-42) Amyloid Fibrils. Becker N, Frieg B, Gremer L, Kupreichyk T, Gardon L, Freiburg P, Neudecker P, Willbold D, Gohlke H, Heise H. J Am Chem Soc 145 2161-2169 (2023)
  34. Comparative Exploratory Analysis of Intrinsically Disordered Protein Dynamics Using Machine Learning and Network Analytic Methods. Grazioli G, Martin RW, Butts CT. Front Mol Biosci 6 42 (2019)
  35. Complete aggregation pathway of amyloid β (1-40) and (1-42) resolved on an atomically clean interface. Nirmalraj PN, List J, Battacharya S, Howe G, Xu L, Thompson D, Mayer M. Sci Adv 6 eaaz6014 (2020)
  36. Computational Investigations into Two-Photon Fibril Imaging Using the DANIR-2c Probe. Murugan NA, Zaleśny R. J Phys Chem B 127 3119-3125 (2023)
  37. Editorial Copper binding and protein aggregation: a journey from the brain to the human lens. Posadas Y, Sánchez-López C, Quintanar L. RSC Chem Biol 4 974-985 (2023)
  38. Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-β Peptides Revealed by Molecular Dynamics Simulations. Liu Z, Zou Y, Zhang Q, Chen P, Liu Y, Qian Z. Int J Mol Sci 20 (2019)
  39. Effect of Lauric Acid on the Stability of Aβ42 Oligomers. Khatua P, Jana AK, Hansmann UHE. ACS Omega 6 5795-5804 (2021)
  40. Emergence of Barrel Motif in Amyloid-β Trimer: A Computational Study. Nguyen HL, Linh HQ, Matteini P, La Penna G, Li MS. J Phys Chem B 124 10617-10631 (2020)
  41. Energy landscapes of Aβ monomers are sculpted in accordance with Ostwald's rule of stages. Chakraborty D, Straub JE, Thirumalai D. Sci Adv 9 eadd6921 (2023)
  42. Epitope alteration by small molecules and applications in drug discovery. Zhu B, Yang J, Van R, Yang F, Yu Y, Yu A, Ran K, Yin K, Liang Y, Shen X, Yin W, Choi SH, Lu Y, Wang C, Shao Y, Shi L, Tanzi RE, Zhang C, Cheng Y, Zhang Z, Ran C. Chem Sci 13 8104-8116 (2022)
  43. Fibril Surface-Dependent Amyloid Precursors Revealed by Coarse-Grained Molecular Dynamics Simulation. Ma YW, Lin TY, Tsai MY. Front Mol Biosci 8 719320 (2021)
  44. Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease. Picón-Pagès P, Bonet J, García-García J, Garcia-Buendia J, Gutierrez D, Valle J, Gómez-Casuso CES, Sidelkivska V, Alvarez A, Perálvarez-Marín A, Suades A, Fernàndez-Busquets X, Andreu D, Vicente R, Oliva B, Muñoz FJ. Comput Struct Biotechnol J 17 963-971 (2019)
  45. In Silico Analysis of Nanoplastics' and β-amyloid Fibrils' Interactions. Gabbrielli S, Colnaghi L, Mazzuoli-Weber G, Redaelli ACL, Gautieri A. Molecules 28 388 (2023)
  46. Investigating New Applications of a Photoswitchable Fluorescent Norbornadiene as a Multifunctional Probe for Delineation of Amyloid Plaque Polymorphism. Dreos A, Ge J, Najera F, Tebikachew BE, Perez-Inestrosa E, Moth-Poulsen K, Blennow K, Zetterberg H, Hanrieder J. ACS Sens 8 1500-1509 (2023)
  47. Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1-42 Polymerization. Yuan N, Ye L, Sun Y, Wu H, Xiao Z, Fu W, Chen Z, Pei Y, Min Y, Wang D. Int J Mol Sci 24 7673 (2023)
  48. New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding. Sulatskaya AI, Rychkov GN, Sulatsky MI, Mikhailova EV, Melnikova NM, Andozhskaya VS, Kuznetsova IM, Turoverov KK. Int J Mol Sci 23 5513 (2022)
  49. Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers. Mocanu CS, Niculaua M, Zbancioc G, Mangalagiu V, Drochioiu G. Int J Mol Sci 23 2857 (2022)
  50. Picomolar-sensitive β-amyloid fibril fluorophores by tailoring the hydrophobicity of biannulated π-elongated dioxaborine-dyes. An J, Verwilst P, Aziz H, Shin J, Lim S, Kim I, Kim YK, Kim JS. Bioact Mater 13 239-248 (2022)
  51. Sensing Performance Investigations on Two-Photon Fluorescent Probes for Detecting β-Amyloid in Alzheimer's Disease. Zhang Y, Luan N, Li K, Leng J, Hu W. Sensors (Basel) 20 (2020)
  52. Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments. Galzitskaya OV, Surin AK, Glyakina AV, Rogachevsky VV, Selivanova OM. J Alzheimers Dis Rep 2 181-199 (2018)
  53. Site-specific structural order in Alzheimer's Aβ42 fibrils. Wang H, Lee YK, Xue C, Guo Z. R Soc Open Sci 5 180166 (2018)
  54. Small-angle X-ray microdiffraction from fibrils embedded in tissue thin sections. Nepal P, Al Bashit A, Yang L, Makowski L. J Appl Crystallogr 55 1562-1571 (2022)
  55. Structure-based inhibitors of amyloid beta core suggest a common interface with tau. Griner SL, Seidler P, Bowler J, Murray KA, Yang TP, Sahay S, Sawaya MR, Cascio D, Rodriguez JA, Philipp S, Sosna J, Glabe CG, Gonen T, Eisenberg DS. Elife 8 (2019)
  56. Structures of brain-derived 42-residue amyloid-β fibril polymorphs with unusual molecular conformations and intermolecular interactions. Lee M, Yau WM, Louis JM, Tycko R. Proc Natl Acad Sci U S A 120 e2218831120 (2023)
  57. Surveying the Energy Landscapes of Aβ Fibril Polymorphism. Chen M, Schafer NP, Wolynes PG. J Phys Chem B 122 11414-11430 (2018)
  58. The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42. Gautieri A, Beeg M, Gobbi M, Rigoldi F, Colombo L, Salmona M. Int J Mol Sci 20 (2019)
  59. The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure. Acharya A, Stockmann J, Beyer L, Rudack T, Nabers A, Gumbart JC, Gerwert K, Batista VS. Biophys J 119 349-359 (2020)
  60. Towards mechanistic models of mutational effects: Deep learning on Alzheimer's Aβ peptide. Wang B, Razavi S, Gamazon ER. Comput Struct Biotechnol J 21 2434-2445 (2023)
  61. Versatile Dicyanomethylene-Based Fluorescent Probes for the Detection of β-Amyloid in Alzheimer's Disease: A Theoretical Perspective. Zhang M, Fu H, Hu W, Leng J, Zhang Y. Int J Mol Sci 23 8619 (2022)


Reviews citing this publication (87)

  1. Alzheimer's disease. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Lancet 397 1577-1590 (2021)
  2. A new era for understanding amyloid structures and disease. Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. Nat. Rev. Mol. Cell Biol. 19 755-773 (2018)
  3. High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease. Sahoo BR, Cox SJ, Ramamoorthy A. Chem Commun (Camb) 56 4627-4639 (2020)
  4. MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments. Martins PM, Navarro S, Silva A, Pinto MF, Sárkány Z, Figueiredo F, Pereira PJB, Pinheiro F, Bednarikova Z, Burdukiewicz M, Galzitskaya OV, Gazova Z, Gomes CM, Pastore A, Serpell LC, Skrabana R, Smirnovas V, Ziaunys M, Otzen DE, Ventura S, Macedo-Ribeiro S. Front Mol Neurosci 13 582488 (2020)
  5. Cryo-EM in drug discovery: achievements, limitations and prospects. Renaud JP, Chari A, Ciferri C, Liu WT, Rémigy HW, Stark H, Wiesmann C. Nat Rev Drug Discov 17 471-492 (2018)
  6. Modulation of Amyloid States by Molecular Chaperones. Wentink A, Nussbaum-Krammer C, Bukau B. Cold Spring Harb Perspect Biol 11 (2019)
  7. Multicomponent peptide assemblies. Raymond DM, Nilsson BL. Chem Soc Rev 47 3659-3720 (2018)
  8. The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease. Lau HHC, Ingelsson M, Watts JC. Acta Neuropathol 142 17-39 (2021)
  9. Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy. van der Wel PCA. Solid State Nucl Magn Reson 88 1-14 (2017)
  10. Secondary nucleation in amyloid formation. Törnquist M, Michaels TCT, Sanagavarapu K, Yang X, Meisl G, Cohen SIA, Knowles TPJ, Linse S. Chem. Commun. (Camb.) 54 8667-8684 (2018)
  11. Selective vulnerability in neurodegenerative diseases. Fu H, Hardy J, Duff KE. Nat. Neurosci. 21 1350-1358 (2018)
  12. Structure and Function of Alzheimer's Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review. Agrawal N, Skelton AA. Protein J 38 425-434 (2019)
  13. Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology. Rahman MM, Lendel C. Mol Neurodegener 16 59 (2021)
  14. No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. Kell DB, Pretorius E. Biol Rev Camb Philos Soc 93 1518-1557 (2018)
  15. β-Amyloid aggregation and heterogeneous nucleation. Srivastava AK, Pittman JM, Zerweck J, Venkata BS, Moore PC, Sachleben JR, Meredith SC. Protein Sci 28 1567-1581 (2019)
  16. Biomolecular Assemblies: Moving from Observation to Predictive Design. Wilson CJ, Bommarius AS, Champion JA, Chernoff YO, Lynn DG, Paravastu AK, Liang C, Hsieh MC, Heemstra JM. Chem. Rev. 118 11519-11574 (2018)
  17. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology. Coskuner-Weber O, Uversky VN. Int J Mol Sci 19 (2018)
  18. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Jucker M, Walker LC. Nat. Neurosci. 21 1341-1349 (2018)
  19. Structural and Functional Insights into α-Synuclein Fibril Polymorphism. Mehra S, Gadhe L, Bera R, Sawner AS, Maji SK. Biomolecules 11 1419 (2021)
  20. The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease. Sun J, Martin JM, Vanderpoel V, Sumbria RK. Neuromolecular Med 21 12-24 (2019)
  21. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease. Chan HJ, Yanshree, Roy J, Tipoe GL, Fung ML, Lim LW. Int J Mol Sci 22 10151 (2021)
  22. Amyloid Polymorphism in the Protein Folding and Aggregation Energy Landscape. Adamcik J, Mezzenga R. Angew. Chem. Int. Ed. Engl. 57 8370-8382 (2018)
  23. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG, Nowick JS. Acc. Chem. Res. 51 706-718 (2018)
  24. Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins. Ulamec SM, Brockwell DJ, Radford SE. Front Neurosci 14 611285 (2020)
  25. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression. Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F. Int J Mol Sci 24 1869 (2023)
  26. Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer's Disease Development. Urban AS, Pavlov KV, Kamynina AV, Okhrimenko IS, Arseniev AS, Bocharov EV. Molecules 26 2897 (2021)
  27. Understanding the invisible hands of sample preparation for cryo-EM. Weissenberger G, Henderikx RJM, Peters PJ. Nat Methods 18 463-471 (2021)
  28. Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran. Grossmann K. Int J Mol Sci 22 4805 (2021)
  29. Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology? Vignon A, Salvador-Prince L, Lehmann S, Perrier V, Torrent J. Int J Mol Sci 22 8769 (2021)
  30. From structure to application: Progress and opportunities in peptide materials development. Lopez-Silva TL, Schneider JP. Curr Opin Chem Biol 64 131-144 (2021)
  31. Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection. Brown MR, Radford SE, Hewitt EW. Front Mol Neurosci 13 609073 (2020)
  32. Protein assembly systems in natural and synthetic biology. Chiesa G, Kiriakov S, Khalil AS. BMC Biol 18 35 (2020)
  33. Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease. Plascencia-Villa G, Perry G. Antioxidants (Basel) 12 1628 (2023)
  34. Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates. Kundel F, Tosatto L, Whiten DR, Wirthensohn DC, Horrocks MH, Klenerman D. FEBS J. 285 3604-3630 (2018)
  35. Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates. Papadopoulos N, Suelves N, Perrin F, Vadukul DM, Vrancx C, Constantinescu SN, Kienlen-Campard P. Biomedicines 10 2753 (2022)
  36. Structures of Pathological and Functional Amyloids and Prions, a Solid-State NMR Perspective. Daskalov A, El Mammeri N, Lends A, Shenoy J, Lamon G, Fichou Y, Saad A, Martinez D, Morvan E, Berbon M, Grélard A, Kauffmann B, Ferber M, Bardiaux B, Habenstein B, Saupe SJ, Loquet A. Front Mol Neurosci 14 670513 (2021)
  37. Supramolecular Architectures of Nucleic Acid/Peptide Hybrids. Higashi SL, Rozi N, Hanifah SA, Ikeda M. Int J Mol Sci 21 E9458 (2020)
  38. An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure. Boopathi S, Poma AB, Garduño-Juárez R. Int J Mol Sci 22 10798 (2021)
  39. Bacterial Protein Homeostasis Disruption as a Therapeutic Intervention. Khodaparast L, Wu G, Khodaparast L, Schmidt BZ, Rousseau F, Schymkowitz J. Front Mol Biosci 8 681855 (2021)
  40. Big versus small: The impact of aggregate size in disease. Hnath B, Chen J, Reynolds J, Choi E, Wang J, Zhang D, Sha CM, Dokholyan NV. Protein Sci 32 e4686 (2023)
  41. Electron cryomicroscopy as a powerful tool in biomedical research. Quentin D, Raunser S. J. Mol. Med. 96 483-493 (2018)
  42. Emerging Roles of Functional Bacterial Amyloids in Gene Regulation, Toxicity, and Immunomodulation. Salinas N, Povolotsky TL, Landau M, Kolodkin-Gal I. Microbiol Mol Biol Rev 85 (2020)
  43. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation. Bhasne K, Mukhopadhyay S. Proteomics 18 e1800059 (2018)
  44. Membranes as modulators of amyloid protein misfolding and target of toxicity. Rawat A, Langen R, Varkey J. Biochim Biophys Acta Biomembr (2018)
  45. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Scheres SHW, Ryskeldi-Falcon B, Goedert M. Nature 621 701-710 (2023)
  46. Single Molecule Characterization of Amyloid Oligomers. Yang J, Perrett S, Wu S. Molecules 26 948 (2021)
  47. Two decades of progress in structural and dynamic studies of amyloids by solid-state NMR. Jaroniec CP. J Magn Reson 306 42-47 (2019)
  48. Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta. Wagner WJ, Gross ML. Mass Spectrom Rev (2022)
  49. Advancements of the sFIDA method for oligomer-based diagnostics of neurodegenerative diseases. Kulawik A, Heise H, Zafiu C, Willbold D, Bannach O. FEBS Lett. 592 516-534 (2018)
  50. Advances in methods for atomic resolution macromolecular structure determination. Thompson MC, Yeates TO, Rodriguez JA. F1000Res 9 (2020)
  51. Agglomeration: when folded proteins clump together. Romero-Romero ML, Garcia-Seisdedos H. Biophys Rev 15 1987-2003 (2023)
  52. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Long JM, Holtzman DM. Cell 179 312-339 (2019)
  53. Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies. Yang H, Li J, Li X, Ma L, Hou M, Zhou H, Zhou R. Front Mol Neurosci 15 927530 (2022)
  54. Catalytic Amyloids as Novel Synthetic Hydrolases. Duran-Meza E, Diaz-Espinoza R. Int J Mol Sci 22 9166 (2021)
  55. Challenges in sample preparation and structure determination of amyloids by cryo-EM. Zielinski M, Röder C, Schröder GF. J Biol Chem 297 100938 (2021)
  56. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Li D, Liu C. Nat Rev Neurosci 23 523-534 (2022)
  57. Congo Red and amyloids: history and relationship. Yakupova EI, Bobyleva LG, Vikhlyantsev IM, Bobylev AG. Biosci. Rep. 39 (2019)
  58. Cryo-EM of amyloid fibrils and cellular aggregates. Fitzpatrick AW, Saibil HR. Curr. Opin. Struct. Biol. 58 34-42 (2019)
  59. Current understanding of metal-dependent amyloid-β aggregation and toxicity. Yi Y, Lim MH. RSC Chem Biol 4 121-131 (2023)
  60. Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease? Willbold D, Kutzsche J. Molecules 24 (2019)
  61. Elucidating Tau function and dysfunction in the era of cryo-EM. Lippens G, Gigant B. J. Biol. Chem. 294 9316-9325 (2019)
  62. Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity. Bhopatkar AA, Kayed R. J Biol Chem 299 105122 (2023)
  63. General Principles Underpinning Amyloid Structure. Taylor AIP, Staniforth RA. Front Neurosci 16 878869 (2022)
  64. Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease. Li D, Liu C. Nat Chem Biol 17 237-245 (2021)
  65. High-Speed Atomic Force Microscopy Reveals the Structural Dynamics of the Amyloid-β and Amylin Aggregation Pathways. Watanabe-Nakayama T, Sahoo BR, Ramamoorthy A, Ono K. Int J Mol Sci 21 (2020)
  66. Illuminating amyloid fibrils: Fluorescence-based single-molecule approaches. Rice LJ, Ecroyd H, van Oijen AM. Comput Struct Biotechnol J 19 4711-4724 (2021)
  67. Interaction of Proteins Involved in Neuronal Proteinopathies. Kulichikhin KY, Malikova OA, Zobnina AE, Zalutskaya NM, Rubel AA. Life (Basel) 13 1954 (2023)
  68. Investigation of the Relationship between Apolipoprotein E Alleles and Serum Lipids in Alzheimer's Disease: A Meta-Analysis. Xu H, Fu J, Mohammed Nazar RB, Yang J, Chen S, Huang Y, Bao T, Chen X. Brain Sci 13 1554 (2023)
  69. Metal-Organic Frameworks as Sensors for Human Amyloid Diseases. Leite JP, Figueira F, Mendes RF, Almeida Paz FA, Gales L. ACS Sens 8 1033-1053 (2023)
  70. Molecular Dynamics Simulation Studies on the Aggregation of Amyloid-β Peptides and Their Disaggregation by Ultrasonic Wave and Infrared Laser Irradiation. Okumura H, Itoh SG. Molecules 27 2483 (2022)
  71. Molecular mechanisms of amyloid disaggregation. Low KJY, Venkatraman A, Mehta JS, Pervushin K. J Adv Res 36 113-132 (2022)
  72. Neglected N-Truncated Amyloid-β Peptide and Its Mixed Cu-Zn Complexes. Frączyk T, Cieplak P. Protein J 41 361-368 (2022)
  73. Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer's Pathogenesis. Penke B, Szűcs M, Bogár F. Molecules 25 (2020)
  74. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives. Schilling S, Rahfeld JU, Lues I, Lemere CA. Molecules 23 (2018)
  75. Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-β plaques in brain tissues and living mice. Yan C, Dai J, Yao Y, Fu W, Tian H, Zhu WH, Guo Z. Nat Protoc 18 1316-1336 (2023)
  76. Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics. Gerasimova EM, Fedotov SA, Kachkin DV, Vashukova ES, Glotov AS, Chernoff YO, Rubel AA. Int J Mol Sci 20 (2019)
  77. Protein nanofibrils and their use as building blocks of sustainable materials. Lendel C, Solin N. RSC Adv 11 39188-39215 (2021)
  78. Protein-Based Biological Materials: Molecular Design and Artificial Production. Miserez A, Yu J, Mohammadi P. Chem Rev 123 2049-2111 (2023)
  79. Quo Vadis Biomolecular NMR Spectroscopy? Selenko P. Int J Mol Sci 20 (2019)
  80. Receptor Recycling by Retromer. Carosi JM, Denton D, Kumar S, Sargeant TJ. Mol Cell Biol 43 317-334 (2023)
  81. Role of the Extracellular Matrix in Alzheimer's Disease. Sun Y, Xu S, Jiang M, Liu X, Yang L, Bai Z, Yang Q. Front Aging Neurosci 13 707466 (2021)
  82. Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains. Hadi Alijanvand S, Peduzzo A, Buell AK. Front Mol Biosci 8 669994 (2021)
  83. Supramolecular assembly of protein building blocks: from folding to function. Kim NH, Choi H, Shahzad ZM, Ki H, Lee J, Chae H, Kim YH. Nano Converg 9 4 (2022)
  84. The Application of Bio-orthogonality for In Vivo Animal Imaging. Yang J, Zhu B, Ran C. Chem Biomed Imaging 1 434-447 (2023)
  85. The Role of α-sheet in Amyloid Oligomer Aggregation and Toxicity. Bi TM, Daggett V. Yale J Biol Med 91 247-255 (2018)
  86. The impact of water on the ambivalent behavior and paradoxical phenomenon of the amyloid-β fibril protein. Vajda T, Perczel A. Biomol Concepts 8 213-220 (2017)
  87. The role of heat shock proteins in preventing amyloid toxicity. Törner R, Kupreichyk T, Hoyer W, Boisbouvier J. Front Mol Biosci 9 1045616 (2022)

Articles citing this publication (215)

  1. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Lee M, Ghosh U, Thurber KR, Kato M, Tycko R. Nat Commun 11 5735 (2020)
  2. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils. Röder C, Kupreichyk T, Gremer L, Schäfer LU, Pothula KR, Ravelli RBG, Willbold D, Hoyer W, Schröder GF. Nat Struct Mol Biol 27 660-667 (2020)
  3. The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils. Thacker D, Sanagavarapu K, Frohm B, Meisl G, Knowles TPJ, Linse S. Proc Natl Acad Sci U S A 117 25272-25283 (2020)
  4. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Häsler LM, Baumann F, Nyström S, Portelius E, Blennow K, Lashley T, Fox NC, Sepulveda-Falla D, Glatzel M, Oblak AL, Ghetti B, Nilsson KPR, Hammarström P, Staufenbiel M, Walker LC, Jucker M. Proc. Natl. Acad. Sci. U.S.A. 114 13018-13023 (2017)
  5. Cryo-EM structure of alpha-synuclein fibrils. Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, Britschgi M, Stahlberg H. Elife 7 (2018)
  6. Architecture of the flexible tail tube of bacteriophage SPP1. Zinke M, Sachowsky KAA, Öster C, Zinn-Justin S, Ravelli R, Schröder GF, Habeck M, Lange A. Nat Commun 11 5759 (2020)
  7. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Li Q, Babinchak WM, Surewicz WK. Nat Commun 12 1620 (2021)
  8. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. Nat Struct Mol Biol 26 619-627 (2019)
  9. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, Zhang X, Li D, Liu C, Li X. Cell Res. 28 897-903 (2018)
  10. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Gallardo R, Iadanza MG, Xu Y, Heath GR, Foster R, Radford SE, Ranson NA. Nat Struct Mol Biol 27 1048-1056 (2020)
  11. Observation of β-Amyloid Peptide Oligomerization by Pressure-Jump NMR Spectroscopy. Barnes CA, Robertson AJ, Louis JM, Anfinrud P, Bax A. J Am Chem Soc 141 13762-13766 (2019)
  12. Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations. Ni X, McGlinchey RP, Jiang J, Lee JC. J Mol Biol 431 3913-3919 (2019)
  13. Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain. Aoyagi A, Condello C, Stöhr J, Yue W, Rivera BM, Lee JC, Woerman AL, Halliday G, van Duinen S, Ingelsson M, Lannfelt L, Graff C, Bird TD, Keene CD, Seeley WW, DeGrado WF, Prusiner SB. Sci Transl Med 11 (2019)
  14. Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage. Ciudad S, Puig E, Botzanowski T, Meigooni M, Arango AS, Do J, Mayzel M, Bayoumi M, Chaignepain S, Maglia G, Cianferani S, Orekhov V, Tajkhorshid E, Bardiaux B, Carulla N. Nat Commun 11 3014 (2020)
  15. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Amin L, Harris DA. Nat Commun 12 3451 (2021)
  16. Combined 1H-Detected Solid-State NMR Spectroscopy and Electron Cryotomography to Study Membrane Proteins across Resolutions in Native Environments. Baker LA, Sinnige T, Schellenberger P, de Keyzer J, Siebert CA, Driessen AJM, Baldus M, Grünewald K. Structure 26 161-170.e3 (2018)
  17. Asparagine and Glutamine Side-Chains and Ladders in HET-s(218-289) Amyloid Fibrils Studied by Fast Magic-Angle Spinning NMR. Wiegand T, Malär AA, Cadalbert R, Ernst M, Böckmann A, Meier BH. Front Mol Biosci 7 582033 (2020)
  18. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases. Zhang W, Falcon B, Murzin AG, Fan J, Crowther RA, Goedert M, Scheres SH. Elife 8 (2019)
  19. Protein Footprinting via Covalent Protein Painting Reveals Structural Changes of the Proteome in Alzheimer's Disease. Bamberger C, Pankow S, Martínez-Bartolomé S, Ma M, Diedrich J, Rissman RA, Yates JR. J Proteome Res 20 2762-2771 (2021)
  20. Templating S100A9 amyloids on Aβ fibrillar surfaces revealed by charge detection mass spectrometry, microscopy, kinetic and microfluidic analyses. Pansieri J, Iashchishyn IA, Fakhouri H, Ostojić L, Malisauskas M, Musteikyte G, Smirnovas V, Schneider MM, Scheidt T, Xu CK, Meisl G, Knowles TPJ, Gazit E, Antoine R, Morozova-Roche LA. Chem Sci 11 7031-7039 (2020)
  21. Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance. Atrián-Blasco E, Gonzalez P, Santoro A, Alies B, Faller P, Hureau C. Coord Chem Rev 375 38-55 (2018)
  22. Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting. Schützmann MP, Hasecke F, Bachmann S, Zielinski M, Hänsch S, Schröder GF, Zempel H, Hoyer W. Nat Commun 12 4634 (2021)
  23. Structural Identification of Individual Helical Amyloid Filaments by Integration of Cryo-Electron Microscopy-Derived Maps in Comparative Morphometric Atomic Force Microscopy Image Analysis. Lutter L, Al-Hilaly YK, Serpell CJ, Tuite MF, Wischik CM, Serpell LC, Xue WF. J Mol Biol 434 167466 (2022)
  24. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. König AS, Rösener NS, Gremer L, Tusche M, Flender D, Reinartz E, Hoyer W, Neudecker P, Willbold D, Heise H. J Biol Chem 296 100499 (2021)
  25. Amyloid-β peptide dimers undergo a random coil to β-sheet transition in the aqueous phase but not at the neuronal membrane. Fatafta H, Khaled M, Owen MC, Sayyed-Ahmad A, Strodel B. Proc Natl Acad Sci U S A 118 e2106210118 (2021)
  26. Comparing the Aggregation Free Energy Landscapes of Amyloid Beta(1-42) and Amyloid Beta(1-40). Zheng W, Tsai MY, Wolynes PG. J. Am. Chem. Soc. 139 16666-16676 (2017)
  27. Conformational Dynamics and Stability of U-Shaped and S-Shaped Amyloid β Assemblies. Grasso G, Rebella M, Muscat S, Morbiducci U, Tuszynski J, Danani A, Deriu MA. Int J Mol Sci 19 (2018)
  28. Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1-42 aggregates. Zhaliazka K, Matveyenka M, Kurouski D. FEBS J 290 3203-3220 (2023)
  29. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease. Zhang S, Liu YQ, Jia C, Lim YJ, Feng G, Xu E, Long H, Kimura Y, Tao Y, Zhao C, Wang C, Liu Z, Hu JJ, Ma MR, Liu Z, Jiang L, Li D, Wang R, Dawson VL, Dawson TM, Li YM, Mao X, Liu C. Proc Natl Acad Sci U S A 118 e2011196118 (2021)
  30. Nanoscale Infrared Spectroscopy Identifies Structural Heterogeneity in Individual Amyloid Fibrils and Prefibrillar Aggregates. Banerjee S, Holcombe B, Ringold S, Foes A, Naik T, Baghel D, Ghosh A. J Phys Chem B 126 5832-5841 (2022)
  31. Probing the Structure of Toxic Amyloid-β Oligomers with Electron Spin Resonance and Molecular Modeling. Banchelli M, Cascella R, D'Andrea C, La Penna G, Li MS, Machetti F, Matteini P, Pizzanelli S. ACS Chem Neurosci 12 1150-1161 (2021)
  32. Spontaneous Formation of β-sheet Nano-barrels during the Early Aggregation of Alzheimer's Amyloid Beta. Sun Y, Kakinen A, Wan X, Moriarty N, Hunt CPJ, Li Y, Andrikopoulos N, Nandakumar A, Davis TP, Parish CL, Song Y, Ke PC, Ding F. Nano Today 38 101125 (2021)
  33. Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation. Windsor PK, Plassmeyer SP, Mattock DS, Bradfield JC, Choi EY, Miller BR, Han BH. Int J Mol Sci 22 2888 (2021)
  34. Hybrids of oxoisoaporphine-tetrahydroisoquinoline: novel multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease. Chen Y, Su C, Wang L, Qin J, Wei S, Tang H. Mol Divers 23 709-722 (2019)
  35. Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation. Hasecke F, Niyangoda C, Borjas G, Pan J, Matthews G, Muschol M, Hoyer W. Angew Chem Int Ed Engl 60 3016-3021 (2021)
  36. Segmental structural dynamics in Aβ42 globulomers. Yoon A, Zhen J, Guo Z. Biochem Biophys Res Commun 545 119-124 (2021)
  37. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology. Gnoth K, Piechotta A, Kleinschmidt M, Konrath S, Schenk M, Taudte N, Ramsbeck D, Rieckmann V, Geissler S, Eichentopf R, Barendrecht S, Hartlage-Rübsamen M, Demuth HU, Roßner S, Cynis H, Rahfeld JU, Schilling S. Alzheimers Res Ther 12 149 (2020)
  38. pH Dependence of Amyloid-β Fibril Assembly Kinetics: Unravelling the Microscopic Molecular Processes. Tian Y, Viles JH. Angew Chem Int Ed Engl 61 e202210675 (2022)
  39. 3D-visualization of amyloid-β oligomer interactions with lipid membranes by cryo-electron tomography. Tian Y, Liang R, Kumar A, Szwedziak P, Viles JH. Chem Sci 12 6896-6907 (2021)
  40. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy. Fändrich M, Nyström S, Nilsson KPR, Böckmann A, LeVine H, Hammarström P. J. Intern. Med. 283 218-237 (2018)
  41. Amyloid particles facilitate surface-catalyzed cross-seeding by acting as promiscuous nanoparticles. Koloteva-Levine N, Aubrey LD, Marchante R, Purton TJ, Hiscock JR, Tuite MF, Xue WF. Proc Natl Acad Sci U S A 118 e2104148118 (2021)
  42. Assessing Reproducibility in Amyloid β Research: Impact of Aβ Sources on Experimental Outcomes. Foley AR, Raskatov JA. Chembiochem 21 2425-2430 (2020)
  43. C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers. Nanaura H, Kawamukai H, Fujiwara A, Uehara T, Aiba Y, Nakanishi M, Shiota T, Hibino M, Wiriyasermkul P, Kikuchi S, Nagata R, Matsubayashi M, Shinkai Y, Niwa T, Mannen T, Morikawa N, Iguchi N, Kiriyama T, Morishima K, Inoue R, Sugiyama M, Oda T, Kodera N, Toma-Fukai S, Sato M, Taguchi H, Nagamori S, Shoji O, Ishimori K, Matsumura H, Sugie K, Saio T, Yoshizawa T, Mori E. Nat Commun 12 5301 (2021)
  44. Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores. Cao Q, Boyer DR, Sawaya MR, Abskharon R, Saelices L, Nguyen BA, Lu J, Murray KA, Kandeel F, Eisenberg DS. Nat Struct Mol Biol 28 724-730 (2021)
  45. Direct Nanospectroscopic Verification of the Amyloid Aggregation Pathway. Lipiec E, Perez-Guaita D, Kaderli J, Wood BR, Zenobi R. Angew. Chem. Int. Ed. Engl. 57 8519-8524 (2018)
  46. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats. Nan S, Wang P, Zhang Y, Fan J. Drug Des Devel Ther 15 2013-2024 (2021)
  47. Femtosecond X-ray coherent diffraction of aligned amyloid fibrils on low background graphene. Seuring C, Ayyer K, Filippaki E, Barthelmess M, Longchamp JN, Ringler P, Pardini T, Wojtas DH, Coleman MA, Dörner K, Fuglerud S, Hammarin G, Habenstein B, Langkilde AE, Loquet A, Meents A, Riek R, Stahlberg H, Boutet S, Hunter MS, Koglin J, Liang M, Ginn HM, Millane RP, Frank M, Barty A, Chapman HN. Nat Commun 9 1836 (2018)
  48. Impact of Electronic Polarization on Preformed, β-Strand Rich Homogenous and Heterogenous Amyloid Oligomers. King KM, Sharp AK, Davidson DS, Brown AM, Lemkul JA. J Comput Biophys Chem 21 449-460 (2022)
  49. Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptides. Cavini IA, Munte CE, Erlach MB, van Groen T, Kadish I, Zhang T, Ziehm T, Nagel-Steger L, Kutzsche J, Kremer W, Willbold D, Kalbitzer HR. Chem. Commun. (Camb.) 54 3294-3297 (2018)
  50. Innovative IgG Biomarkers Based on Phage Display Microbial Amyloid Mimotope for State and Stage Diagnosis in Alzheimer's Disease. De Plano LM, Carnazza S, Franco D, Rizzo MG, Conoci S, Petralia S, Nicoletti A, Zappia M, Campolo M, Esposito E, Cuzzocrea S, Guglielmino SPP. ACS Chem Neurosci 11 1013-1026 (2020)
  51. Insights Into the Mechanism of Tyrosine Nitration in Preventing β-Amyloid Aggregation in Alzheimer's Disease. Zhao J, Shi Q, Zheng Y, Liu Q, He Z, Gao Z, Liu Q. Front Mol Neurosci 14 619836 (2021)
  52. Mass Spectrometry-Based Protein Footprinting for Higher-Order Structure Analysis: Fundamentals and Applications. Liu XR, Zhang MM, Gross ML. Chem Rev 120 4355-4454 (2020)
  53. Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ1-42 peptide aggregation. Jin Y, Sun Y, Chen Y, Lei J, Wei G. Phys Chem Chem Phys 21 10981-10991 (2019)
  54. Nanoscale Infrared Spectroscopy Identifies Parallel to Antiparallel β-Sheet Transformation of Aβ Fibrils. Banerjee S, Baghel D, Hasan Ul Iqbal M, Ghosh A. J Phys Chem Lett 13 10522-10526 (2022)
  55. Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies. Galzitskaya OV. Front Mol Neurosci 12 319 (2019)
  56. Polymorphic Aβ42 fibrils adopt similar secondary structure but differ in cross-strand side chain stacking interactions within the same β-sheet. Wang H, Duo L, Hsu F, Xue C, Lee YK, Guo Z. Sci Rep 10 5720 (2020)
  57. Quantification of amyloid fibril polymorphism by nano-morphometry reveals the individuality of filament assembly. Aubrey LD, Blakeman BJF, Lutter L, Serpell CJ, Tuite MF, Serpell LC, Xue WF. Commun Chem 3 125 (2020)
  58. Single-Molecule Localization Microscopy of 3D Orientation and Anisotropic Wobble Using a Polarized Vortex Point Spread Function. Ding T, Lew MD. J Phys Chem B 125 12718-12729 (2021)
  59. Somatostatin in Alzheimer's disease: A new Role for an Old Player. Solarski M, Wang H, Wille H, Schmitt-Ulms G. Prion 12 1-8 (2018)
  60. The molecular basis of Alzheimer's plaques. Pospich S, Raunser S. Science 358 45-46 (2017)
  61. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease. Lee MC, Yu WC, Shih YH, Chen CY, Guo ZH, Huang SJ, Chan JCC, Chen YR. Sci Rep 8 4772 (2018)
  62. A Hybrid Structural Method for Investigating Low Molecular Weight Oligomeric Structures of Amyloid Beta. Gupta S, Raskatov JA, Ralston CY. Chembiochem 23 e202200333 (2022)
  63. A complete catalog of wild-type Sup35 prion variants and their protein-only propagation. Huang YW, King CY. Curr Genet 66 97-122 (2020)
  64. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein. Rösener NS, Gremer L, Reinartz E, König A, Brener O, Heise H, Hoyer W, Neudecker P, Willbold D. J. Biol. Chem. 293 15748-15764 (2018)
  65. Research Support, Non-U.S. Gov't A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV-1 V3 loop. Kokotidou C, Jonnalagadda SVR, Orr AA, Seoane-Blanco M, Apostolidou CP, van Raaij MJ, Kotzabasaki M, Chatzoudis A, Jakubowski JM, Mossou E, Forsyth VT, Mitchell EP, Bowler MW, Llamas-Saiz AL, Tamamis P, Mitraki A. FEBS Lett. 592 1777-1788 (2018)
  66. A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity. Bouvet P, de Gea P, Aimard M, Chounlamountri N, Honnorat J, Delcros JG, Salin PA, Meissirel C. Aging Cell 22 e13907 (2023)
  67. Alkali ion influence on structure and stability of fibrillar amyloid-β oligomers. Huraskin D, Horn AHC. J Mol Model 25 37 (2019)
  68. Amyloid β 42 fibril structure based on small-angle scattering. Lattanzi V, André I, Gasser U, Dubackic M, Olsson U, Linse S. Proc Natl Acad Sci U S A 118 e2112783118 (2021)
  69. Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity. Rajasekhar K, Samanta S, Bagoband V, Murugan NA, Govindaraju T. iScience 23 101005 (2020)
  70. Aβ and Tau Prions Causing Alzheimer's Disease. Condello C, Merz GE, Aoyagi A, DeGrado WF, Prusiner SB. Methods Mol Biol 2561 293-337 (2023)
  71. Constraints on the Structure of Fibrils Formed by a Racemic Mixture of Amyloid-β Peptides from Solid-State NMR, Electron Microscopy, and Theory. Raskatov JA, Foley AR, Louis JM, Yau WM, Tycko R. J Am Chem Soc 143 13299-13313 (2021)
  72. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient. Swuec P, Lavatelli F, Tasaki M, Paissoni C, Rognoni P, Maritan M, Brambilla F, Milani P, Mauri P, Camilloni C, Palladini G, Merlini G, Ricagno S, Bolognesi M. Nat Commun 10 1269 (2019)
  73. Cryo-electron tomography provides topological insights into mutant huntingtin exon 1 and polyQ aggregates. Galaz-Montoya JG, Shahmoradian SH, Shen K, Frydman J, Chiu W. Commun Biol 4 849 (2021)
  74. Different protonated states at the C-terminal of the amyloid-β peptide modulate the stability of S-shaped protofibril. Yin X, Liu S, Perez-Aguilar JM, Zhou H, Shao Q, Yang Z, Zhou R. J Chem Phys 150 185102 (2019)
  75. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity. Jin Y, Sun Y, Lei J, Wei G. Phys Chem Chem Phys 20 17208-17217 (2018)
  76. Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease. Liu H, Kim C, Haldiman T, Sigurdson CJ, Nyström S, Nilsson KPR, Cohen ML, Wisniewski T, Hammarström P, Safar JG. J Biol Chem 297 101267 (2021)
  77. Early Divergence in Misfolding Pathways of Amyloid-Beta Peptides. Mamone S, Glöggler S, Becker S, Rezaei-Ghaleh N. Chemphyschem 22 2158-2163 (2021)
  78. Research Support, Non-U.S. Gov't Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Aβ. Kapurniotu A. Nat Struct Mol Biol 27 1006-1008 (2020)
  79. Fibrillization of β-Amyloid Peptides via Chemically Modulated Pathway. Guo ZH, Yang CI, Ho CI, Huang SJ, Chen YC, Tai HC, Chan JCC. Chemistry 24 4939-4943 (2018)
  80. Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections. Ohno Y, Murphy R, Choi M, Ou W, Sumbria RK. J Vis Exp (2022)
  81. Gene therapy using Aβ variants for amyloid reduction. Park KW, Wood CA, Li J, Taylor BC, Oh S, Young NL, Jankowsky JL. Mol Ther 29 2294-2307 (2021)
  82. Influence of solubilization and AD-mutations on stability and structure of human presenilins. Yang G, Yu K, Kaitatzi CS, Singh A, Labahn J. Sci Rep 7 17970 (2017)
  83. Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides. Rajpoot J, Crooks EJ, Irizarry BA, Amundson A, Van Nostrand WE, Smith SO. Biochemistry 61 1181-1198 (2022)
  84. Iodine staining as a useful probe for distinguishing insulin amyloid polymorphs. Hiramatsu T, Yamamoto N, Ha S, Masuda Y, Yasuda M, Ishigaki M, Yuzu K, Ozaki Y, Chatani E. Sci Rep 10 16741 (2020)
  85. Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1. Kuhn AJ, Raskatov J. J Alzheimers Dis 74 43-53 (2020)
  86. Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study. Man VH, Lin D, He X, Gao J, Wang J. J Alzheimers Dis 89 107-119 (2022)
  87. Key Residues for the Formation of Aβ42 Amyloid Fibrils. Hsu F, Park G, Guo Z. ACS Omega 3 8401-8407 (2018)
  88. MOMD Analysis of NMR Line Shapes from Aβ-Amyloid Fibrils: A New Tool for Characterizing Molecular Environments in Protein Aggregates. Meirovitch E, Liang Z, Freed JH. J Phys Chem B 122 4793-4801 (2018)
  89. Molecular Determinants of Aβ42 Adsorption to Amyloid Fibril Surfaces. Bellaiche MMJ, Best RB. J Phys Chem Lett 9 6437-6443 (2018)
  90. Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue. Ghosh U, Thurber KR, Yau WM, Tycko R. Proc Natl Acad Sci U S A 118 (2021)
  91. Molecular structure of an N-terminal phosphorylated β-amyloid fibril. Hu ZW, Vugmeyster L, Au DF, Ostrovsky D, Sun Y, Qiang W. Proc. Natl. Acad. Sci. U.S.A. 116 11253-11258 (2019)
  92. Multivariate effects of pH, salt, and Zn2+ ions on Aβ40 fibrillation. Wang H, Wu J, Sternke-Hoffmann R, Zheng W, Mörman C, Luo J. Commun Chem 5 171 (2022)
  93. Mutual population-shift driven antibody-peptide binding elucidated by molecular dynamics simulations. Bekker GJ, Fukuda I, Higo J, Kamiya N. Sci Rep 10 1406 (2020)
  94. Nanoscale structural characterization of transthyretin aggregates formed at different time points of protein aggregation using atomic force microscopy-infrared spectroscopy. Rodriguez A, Ali A, Holman AP, Dou T, Zhaliazka K, Kurouski D. Protein Sci 32 e4838 (2023)
  95. Nature-inspired design and evolution of anti-amyloid antibodies. Julian MC, Rabia LA, Desai AA, Arsiwala A, Gerson JE, Paulson HL, Kane RS, Tessier PM. J Biol Chem 294 8438-8451 (2019)
  96. Out-of-Register Parallel β-Sheets and Antiparallel β-Sheets Coexist in 150-kDa Oligomers Formed by Amyloid-β(1-42). Gao Y, Guo C, Watzlawik JO, Randolph PS, Lee EJ, Huang D, Stagg SM, Zhou HX, Rosenberry TL, Paravastu AK. J Mol Biol 432 4388-4407 (2020)
  97. Oxidation destabilizes toxic amyloid beta peptide aggregation. Razzokov J, Yusupov M, Bogaerts A. Sci Rep 9 5476 (2019)
  98. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Zhao K, Lim YJ, Liu Z, Long H, Sun Y, Hu JJ, Zhao C, Tao Y, Zhang X, Li D, Li YM, Liu C. Proc Natl Acad Sci U S A 117 20305-20315 (2020)
  99. Pathways of amyloid-beta absorption and aggregation in a membranous environment. Sahoo A, Xu H, Matysiak S. Phys Chem Chem Phys 21 8559-8568 (2019)
  100. Protein-to-lipid ratio uniquely changes the rate of lysozyme aggregation but does not significantly alter toxicity of mature protein aggregates. Zhaliazka K, Serada V, Matveyenka M, Rizevsky S, Kurouski D. Biochim Biophys Acta Mol Cell Biol Lipids 1868 159305 (2023)
  101. Pulsed Hydrogen-Deuterium Exchange Reveals Altered Structures and Mechanisms in the Aggregation of Familial Alzheimer's Disease Mutants. Illes-Toth E, Meisl G, Rempel DL, Knowles TPJ, Gross ML. ACS Chem Neurosci 12 1972-1982 (2021)
  102. Quantitative NMR analysis of the mechanism and kinetics of chaperone Hsp104 action on amyloid-β42 aggregation and fibril formation. Ghosh S, Tugarinov V, Clore GM. Proc Natl Acad Sci U S A 120 e2305823120 (2023)
  103. Simulations and Experiments Delineate Amyloid Fibrilization by Peptides Derived from Glaucoma-Associated Myocilin. Wang Y, Gao Y, Hill SE, Huard DJE, Tomlin MO, Lieberman RL, Paravastu AK, Hall CK. J Phys Chem B 122 5845-5850 (2018)
  104. Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients. Ghosh U, Yau WM, Collinge J, Tycko R. Proc Natl Acad Sci U S A 118 e2111863118 (2021)
  105. The residual structure of acid-denatured β2 -microglobulin is relevant to an ordered fibril morphology. Tomiyama R, So M, Yamaguchi K, Miyanoiri Y, Sakurai K. Protein Sci 32 e4487 (2023)
  106. Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology. Paul PS, Cho JY, Wu Q, Karthivashan G, Grabovac E, Wille H, Kulka M, Kar S. J Nanobiotechnology 20 67 (2022)
  107. Unusual binding-site-specific photophysical properties of a benzothiazole-based optical probe in amyloid beta fibrils. Arul Murugan N, Zaleśny R, Ågren H. Phys Chem Chem Phys 20 20334-20339 (2018)
  108. 1H detection and dynamic nuclear polarization-enhanced NMR of Aβ1-42 fibrils. Bahri S, Silvers R, Michael B, Jaudzems K, Lalli D, Casano G, Ouari O, Lesage A, Pintacuda G, Linse S, Griffin RG. Proc Natl Acad Sci U S A 119 e2114413119 (2022)
  109. A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brain. Stern AM, Liu L, Jin S, Liu W, Meunier AL, Ericsson M, Miller MB, Batson M, Sun T, Kathuria S, Reczek D, Pradier L, Selkoe DJ. Brain 145 2528-2540 (2022)
  110. A chemically engineered, stable oligomer mimic of amyloid β42 containing an oxime switch for fibril formation. Yamamoto M, Shinoda K, Ni J, Sasaki D, Kanai M, Sohma Y. Org. Biomol. Chem. 16 6537-6542 (2018)
  111. A near atomic-scale view at the composition of amyloid-beta fibrils by atom probe tomography. Rusitzka KAK, Stephenson LT, Szczepaniak A, Gremer L, Raabe D, Willbold D, Gault B. Sci Rep 8 17615 (2018)
  112. A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease. Ikenoue T, Aprile FA, Sormanni P, Ruggeri FS, Perni M, Heller GT, Haas CP, Middel C, Limbocker R, Mannini B, Michaels TCT, Knowles TPJ, Dobson CM, Vendruscolo M. Sci Rep 10 15280 (2020)
  113. A structural model of the hierarchical assembly of an amyloid nanosheet by an infrared probe technique. Jia B, Sun Y, Yang L, Yu Y, Fan H, Ma G. Phys Chem Chem Phys 20 27261-27271 (2018)
  114. A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation. Sato W, Watanabe-Takahashi M, Murata T, Utsunomiya-Tate N, Motoyama J, Anzai M, Ishihara S, Nishioka N, Uchiyama H, Togashi J, Nishihara S, Kawasaki K, Saito T, Saido TC, Funamoto S, Nishikawa K. Commun Biol 6 383 (2023)
  115. Albumin Alters the Conformational Ensemble of Amyloid-β by Promiscuous Interactions: Implications for Amyloid Inhibition. Xie H, Guo C. Front Mol Biosci 7 629520 (2020)
  116. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease. de Oliveira GAP, Silva JL. Commun Biol 2 374 (2019)
  117. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain. Zhong X, Kumar R, Wang Y, Biverstål H, Ingeborg Jegerschöld C, J B Koeck P, Johansson J, Abelein A, Chen G. ACS Chem Biol 17 2201-2211 (2022)
  118. Amyloid fibril formation kinetics of low-pH denatured bovine PI3K-SH3 monitored by three different NMR techniques. Gardon L, Becker N, Rähse N, Hölbling C, Apostolidis A, Schulz CM, Bochinsky K, Gremer L, Heise H, Lakomek NA. Front Mol Biosci 10 1254721 (2023)
  119. Amyloid-like Behavior of Site-Specifically Citrullinated Myelin Oligodendrocyte Protein (MOG) Peptide Fragments inside EBV-Infected B-Cells Influences Their Cytotoxicity and Autoimmunogenicity. Araman C, van Gent ME, Meeuwenoord NJ, Heijmans N, Marqvorsen MHS, Doelman W, Faber BW, 't Hart BA, Van Kasteren SI. Biochemistry 58 763-775 (2019)
  120. Anticoagulants for Treatment of Alzheimer's Disease. Grossmann K. J Alzheimers Dis 77 1373-1382 (2020)
  121. Atomic structure of PI3-kinase SH3 amyloid fibrils by cryo-electron microscopy. Röder C, Vettore N, Mangels LN, Gremer L, Ravelli RBG, Willbold D, Hoyer W, Buell AK, Schröder GF. Nat Commun 10 3754 (2019)
  122. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression. Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P, Scheltens P, Poirier J, Saftig P, Bateman RJ, Breitner J, Hock C, Multhaup G. Nat Commun 10 2240 (2019)
  123. Binding sites for luminescent amyloid biomarkers from non-biased molecular dynamics simulations. König C, Skånberg R, Hotz I, Ynnerman A, Norman P, Linares M. Chem. Commun. (Camb.) 54 3030-3033 (2018)
  124. Brain structure and structural basis of neurodegenerative diseases. Yang J, Sui SF, Liu Z. Biophys Rep 8 170-181 (2022)
  125. C-Terminal Plays as the Possible Nucleation of the Self-Aggregation of the S-Shape Aβ11-42 Tetramer in Solution: Intensive MD Study. Tung NT, Derreumaux P, Vu VV, Nam PC, Ngo ST. ACS Omega 4 11066-11073 (2019)
  126. Characterization of Amyloidogenic Peptide Aggregability in Helical Subspace. Bhattacharya S, Xu L, Thompson D. Methods Mol Biol 2340 401-448 (2022)
  127. Characterization of amyloid β fibril formation under microgravity conditions. Yagi-Utsumi M, Yanaka S, Song C, Satoh T, Yamazaki C, Kasahara H, Shimazu T, Murata K, Kato K. NPJ Microgravity 6 17 (2020)
  128. Co-aggregation of α-synuclein with amyloid-β stabilizes β-sheet-rich oligomers and enhances the formation of β-barrels. Huang F, Liu Y, Wang Y, Xu J, Lian J, Zou Y, Wang C, Ding F, Sun Y. Phys Chem Chem Phys 25 31604-31614 (2023)
  129. Coexisting order and disorder within a common 40-residue amyloid-β fibril structure in Alzheimer's disease brain tissue. Ghosh U, Yau WM, Tycko R. Chem. Commun. (Camb.) 54 5070-5073 (2018)
  130. Combined High-Pressure and Multiquantum NMR and Molecular Simulation Propose a Role for N-Terminal Salt Bridges in Amyloid-Beta. Vemulapalli SPB, Becker S, Griesinger C, Rezaei-Ghaleh N. J Phys Chem Lett 12 9933-9939 (2021)
  131. Comparative analysis of 13C chemical shifts of β-sheet amyloid proteins and outer membrane proteins. Somberg NH, Gelenter MD, Hong M. J Biomol NMR 75 151-166 (2021)
  132. Conformational heterogeneity coupled with β-fibril formation of a scaffold protein involved in chronic mental illnesses. Cukkemane A, Becker N, Zielinski M, Frieg B, Lakomek NA, Heise H, Schröder GF, Willbold D, Weiergräber OH. Transl Psychiatry 11 639 (2021)
  133. Consecutive Aromatic Residues Are Required for Improved Efficacy of β-Sheet Breakers. Jarmuła A, Zubalska M, Stępkowski D. Int J Mol Sci 23 5247 (2022)
  134. Copper mediated amyloid-β binding to Transthyretin. Ciccone L, Fruchart-Gaillard C, Mourier G, Savko M, Nencetti S, Orlandini E, Servent D, Stura EA, Shepard W. Sci Rep 8 13744 (2018)
  135. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Liberta F, Loerch S, Rennegarbe M, Schierhorn A, Westermark P, Westermark GT, Hazenberg BPC, Grigorieff N, Fändrich M, Schmidt M. Nat Commun 10 1104 (2019)
  136. Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer's disease. Zielinski M, Peralta Reyes FS, Gremer L, Schemmert S, Frieg B, Schäfer LU, Willuweit A, Donner L, Elvers M, Nilsson LNG, Syvänen S, Sehlin D, Ingelsson M, Willbold D, Schröder GF. Nat Neurosci 26 2073-2080 (2023)
  137. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue. Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A, Schmidt M, Sigurdson CJ, Jucker M, Fändrich M. Nat Commun 10 4760 (2019)
  138. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Radamaker L, Lin YH, Annamalai K, Huhn S, Hegenbart U, Schönland SO, Fritz G, Schmidt M, Fändrich M. Nat Commun 10 1103 (2019)
  139. CryoEM structure of the low-complexity domain of hnRNPA2 and its conversion to pathogenic amyloid. Lu J, Cao Q, Hughes MP, Sawaya MR, Boyer DR, Cascio D, Eisenberg DS. Nat Commun 11 4090 (2020)
  140. Cytotoxic Aβ Protofilaments Are Generated in the Process of Aβ Fibril Disaggregation. Kaku T, Tsukakoshi K, Ikebukuro K. Int J Mol Sci 22 12780 (2021)
  141. Decoding the Roles of Amyloid-β (1-42)'s Key Oligomerization Domains toward Designing Epitope-Specific Aggregation Inhibitors. Im D, Kim S, Yoon G, Hyun DG, Eom YG, Lee YE, Sohn CH, Choi JM, Kim HI. JACS Au 3 1065-1075 (2023)
  142. Depletion of amyloid-β peptides from solution by sequestration within fibril-seeded hydrogels. Yau WM, Tycko R. Protein Sci. 27 1218-1230 (2018)
  143. Destabilization potential of beta sheet breaker peptides on Abeta fibril structure: an insight from molecular dynamics simulation study. Jani V, Sonavane U, Joshi R. RSC Adv 11 23557-23573 (2021)
  144. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies. Eraña H, Charco JM, Di Bari MA, Díaz-Domínguez CM, López-Moreno R, Vidal E, González-Miranda E, Pérez-Castro MA, García-Martínez S, Bravo S, Fernández-Borges N, Geijo M, D'Agostino C, Garrido J, Bian J, König A, Uluca-Yazgi B, Sabate R, Khaychuk V, Vanni I, Telling GC, Heise H, Nonno R, Requena JR, Castilla J. PLoS Pathog. 15 e1008117 (2019)
  145. Differences in the free energies between the excited states of Aβ40 and Aβ42 monomers encode their aggregation propensities. Chakraborty D, Straub JE, Thirumalai D. Proc Natl Acad Sci U S A 117 19926-19937 (2020)
  146. Differential Binding and Conformational Dynamics of Tau Microtubule-Binding Repeats with a Preformed Amyloid-β Fibril Seed. Song Z, Gatch AJ, Sun Y, Ding F. ACS Chem Neurosci 14 1321-1330 (2023)
  147. Differentiation of subnucleus-sized oligomers and nucleation-competent assemblies of the Aβ peptide. Pauly T, Zhang T, Sternke-Hoffmann R, Nagel-Steger L, Willbold D. Biophys J 122 269-278 (2023)
  148. Direct Observation of Competing Prion Protein Fibril Populations with Distinct Structures and Kinetics. Sun Y, Jack K, Ercolani T, Sangar D, Hosszu L, Collinge J, Bieschke J. ACS Nano 17 6575-6588 (2023)
  149. Direct Observation of Seeded Conformational Conversion of hIAPP In Silico Reveals the Mechanisms for Morphological Dependence and Asymmetry of Fibril Growth. Huang G, Tang H, Liu Y, Zhang C, Ke PC, Sun Y, Ding F. J Chem Inf Model 63 5863-5873 (2023)
  150. Direct observation of secondary nucleation along the fibril surface of the amyloid β 42 peptide. Thacker D, Barghouth M, Bless M, Zhang E, Linse S. Proc Natl Acad Sci U S A 120 e2220664120 (2023)
  151. Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases. Lim KH. Front Mol Neurosci 12 158 (2019)
  152. Early events in amyloid-β self-assembly probed by time-resolved solid state NMR and light scattering. Jeon J, Yau WM, Tycko R. Nat Commun 14 2964 (2023)
  153. Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning. Gray VE, Sitko K, Kameni FZN, Williamson M, Stephany JJ, Hasle N, Fowler DM. G3 (Bethesda) 9 3683-3689 (2019)
  154. Filamentous Aggregates of Tau Proteins Fulfil Standard Amyloid Criteria Provided by the Fuzzy Oil Drop (FOD) Model. Dułak D, Gadzała M, Banach M, Ptak M, Wiśniowski Z, Konieczny L, Roterman I. Int J Mol Sci 19 (2018)
  155. Formation of Neutral Peptide Aggregates as Studied by Mass-Selective IR Action Spectroscopy. Bakels S, Porskamp SBA, Rijs AM. Angew. Chem. Int. Ed. Engl. 58 10537-10541 (2019)
  156. Full atomistic model of prion structure and conversion. Spagnolli G, Rigoli M, Orioli S, Sevillano AM, Faccioli P, Wille H, Biasini E, Requena JR. PLoS Pathog. 15 e1007864 (2019)
  157. Helix Dipole and Membrane Electrostatics Delineate Conformational Transitions in the Self-Assembly of Amyloidogenic Peptides. Zheng Q, Carty SN, Lazo ND. Langmuir 36 8389-8397 (2020)
  158. High-efficient bacterial production of human ApoA-I amyloidogenic variants. Del Giudice R, Lagerstedt JO. Protein Sci. 27 2101-2109 (2018)
  159. His6, His13, and His14 residues in Aβ 1-40 peptide significantly and specifically affect oligomeric equilibria. Przygońska K, Pacewicz M, Sadowska W, Poznański J, Bal W, Dadlez M. Sci Rep 9 9449 (2019)
  160. Identifying Terminal Assembly Propensity of Amyloidal Peptides by Scanning Tunneling Microscopy. Zheng Y, Xu M, Yu L, Qu F, Lin Y, Xu J, Zou Y, Yang Y, Wang C. Chemphyschem 20 103-107 (2019)
  161. Imaging active site chemistry and protonation states: NMR crystallography of the tryptophan synthase α-aminoacrylate intermediate. Holmes JB, Liu V, Caulkins BG, Hilario E, Ghosh RK, Drago VN, Young RP, Romero JA, Gill AD, Bogie PM, Paulino J, Wang X, Riviere G, Bosken YK, Struppe J, Hassan A, Guidoulianov J, Perrone B, Mentink-Vigier F, Chang CA, Long JR, Hooley RJ, Mueser TC, Dunn MF, Mueller LJ. Proc Natl Acad Sci U S A 119 e2109235119 (2022)
  162. In Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from Porphyromonas gingivalis. Pezzotti G, Adachi T, Imamura H, Bristol DR, Adachi K, Yamamoto T, Kanamura N, Marin E, Zhu W, Kawai T, Mazda O, Kariu T, Waku T, Nichols FC, Riello P, Rizzolio F, Limongi T, Okuma K. Int J Mol Sci 24 13351 (2023)
  163. In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease. Schartmann E, Schemmert S, Niemietz N, Honold D, Ziehm T, Tusche M, Elfgen A, Gering I, Brener O, Shah NJ, Langen KJ, Kutzsche J, Willbold D, Willuweit A. J. Alzheimers Dis. 64 859-873 (2018)
  164. Including residual contact information into replica-exchange MD simulations significantly enriches native-like conformations. Voronin A, Weiel M, Schug A. PLoS One 15 e0242072 (2020)
  165. Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design. Cao Q, Shin WS, Chan H, Vuong CK, Dubois B, Li B, Murray KA, Sawaya MR, Feigon J, Black DL, Eisenberg DS, Jiang L. Nat Chem 10 1213-1221 (2018)
  166. Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection. Kolkwitz PE, Mohrlüder J, Willbold D. Biomolecules 12 157 (2022)
  167. Insights into neurodegeneration from electron microscopy studies. Crowther RA. Biochem Soc Trans 49 2777-2786 (2021)
  168. Integrated NMR and cryo-EM atomic-resolution structure determination of a half-megadalton enzyme complex. Gauto DF, Estrozi LF, Schwieters CD, Effantin G, Macek P, Sounier R, Sivertsen AC, Schmidt E, Kerfah R, Mas G, Colletier JP, Güntert P, Favier A, Schoehn G, Schanda P, Boisbouvier J. Nat Commun 10 2697 (2019)
  169. Interference with Amyloid-β Nucleation by Transient Ligand Interaction. Zhang T, Loschwitz J, Strodel B, Nagel-Steger L, Willbold D. Molecules 24 (2019)
  170. Key Residue for Aggregation of Amyloid-β Peptides. Itoh SG, Yagi-Utsumi M, Kato K, Okumura H. ACS Chem Neurosci 13 3139-3151 (2022)
  171. Magnetoelectric dissociation of Alzheimer's β-amyloid aggregates. Jang J, Park CB. Sci Adv 8 eabn1675 (2022)
  172. Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer's Disease Brain by Autoradiography Using [18F]Flotaza, [125I]IBETA, [124/125I]IPPI and Immunohistochemistry Analysis Using QuPath. Mondal R, Sandhu YK, Kamalia VM, Delaney BA, Syed AU, Nguyen GAH, Moran TR, Limpengco RR, Liang C, Mukherjee J. Biomedicines 11 1033 (2023)
  173. Modulation of Amyloid-β42 Conformation by Small Molecules Through Nonspecific Binding. Liang C, Savinov SN, Fejzo J, Eyles SJ, Chen J. J Chem Theory Comput 15 5169-5174 (2019)
  174. Molecular Structure of Cu(II)-Bound Amyloid-β Monomer Implicated in Inhibition of Peptide Self-Assembly in Alzheimer's Disease. Abelein A, Ciofi-Baffoni S, Mörman C, Kumar R, Giachetti A, Piccioli M, Biverstål H. JACS Au 2 2571-2584 (2022)
  175. Molecular basis for chirality-regulated Aβ self-assembly and receptor recognition revealed by ion mobility-mass spectrometry. Li G, DeLaney K, Li L. Nat Commun 10 5038 (2019)
  176. Molecular dynamics simulations of amyloid-β peptides in heterogeneous environments. Tachi Y, Itoh SG, Okumura H. Biophys Physicobiol 19 1-18 (2022)
  177. Molecular structure of an amyloid fibril formed by FUS low-complexity domain. Sun Y, Zhang S, Hu J, Tao Y, Xia W, Gu J, Li Y, Cao Q, Li D, Liu C. iScience 25 103701 (2022)
  178. N-terminal Domain of Amyloid-β Impacts Fibrillation and Neurotoxicity. Shi JM, Li HY, Liu H, Zhu L, Guo YB, Pei J, An H, Li YS, Li SD, Zhang ZY, Zheng Y. ACS Omega 7 38847-38855 (2022)
  179. NRM 2021 Abstract Booklet. J Cereb Blood Flow Metab 41 11-309 (2021)
  180. NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice. Léger P, Nachman E, Richter K, Tamietti C, Koch J, Burk R, Kummer S, Xin Q, Stanifer M, Bouloy M, Boulant S, Kräusslich HG, Montagutelli X, Flamand M, Nussbaum-Krammer C, Lozach PY. Nat Commun 11 3281 (2020)
  181. Comment New tool to tackle Alzheimer's disease: amyloid-β protofibril-selective antibody AbSL: An Editorial Highlight for 'The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region' on page 736. Molnár E. J. Neurochem. 143 621-623 (2017)
  182. Novel D-A-D based near-infrared probes for the detection of β-amyloid and Tau fibrils in Alzheimer's disease. Li Y, Wang K, Zhou K, Guo W, Dai B, Liang Y, Dai J, Cui M. Chem. Commun. (Camb.) 54 8717-8720 (2018)
  183. Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease. Vicente-Zurdo D, Rosales-Conrado N, León-González ME, Brunetti L, Piemontese L, Pereira-Santos AR, Cardoso SM, Madrid Y, Chaves S, Santos MA. Biomedicines 10 1510 (2022)
  184. Novel small molecular compound 2JY-OBZ4 alleviates AD pathology in cell models via regulating multiple targets. Guo Q, Wu G, Huang F, Wei Z, Wang JZ, Zhang B, Liu R, Yang Y, Wang X, Li HL. Aging (Albany NY) 14 8077-8094 (2022)
  185. Peptide backbone modifications of amyloid β (1-40) impact fibrillation behavior and neuronal toxicity. Schwarze B, Korn A, Höfling C, Zeitschel U, Krueger M, Roßner S, Huster D. Sci Rep 11 23767 (2021)
  186. Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine-based compounds on β-amyloid aggregation. Marasco D, Vicidomini C, Krupa P, Cioffi F, Huy PDQ, Li MS, Florio D, Broersen K, De Pandis MF, Roviello GN. Chem Biol Interact 334 109300 (2021)
  187. Probing Protein Aggregation Using the Coarse-Grained UNRES Force Field. Rojas AV, Maisuradze GG, Scheraga HA, Liwo A. Methods Mol Biol 2340 79-104 (2022)
  188. Probing differences among Aβ oligomers with two triangular trimers derived from Aβ. Kreutzer AG, Guaglianone G, Yoo S, Parrocha CMT, Ruttenberg SM, Malonis RJ, Tong K, Lin YF, Nguyen JT, Howitz WJ, Diab MN, Hamza IL, Lai JR, Wysocki VH, Nowick JS. Proc Natl Acad Sci U S A 120 e2219216120 (2023)
  189. Raman fingerprints of amyloid structures. Flynn JD, Lee JC. Chem. Commun. (Camb.) 54 6983-6986 (2018)
  190. SEVI Inhibits Aβ Amyloid Aggregation by Capping the β-Sheet Elongation Edges. Wang Y, Xu J, Huang F, Yan J, Fan X, Zou Y, Wang C, Ding F, Sun Y. J Chem Inf Model 63 3567-3578 (2023)
  191. Search and Identification of Amyloid Proteins. Belashova TA, Valina AA, Sysoev EI, Velizhanina ME, Zelinsky AA, Galkin AP. Methods Protoc 6 16 (2023)
  192. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Kumar ST, Nazarov S, Porta S, Maharjan N, Cendrowska U, Kabani M, Finamore F, Xu Y, Lee VM, Lashuel HA. Nat Neurosci 26 983-996 (2023)
  193. Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology. Anand B, Wu Q, Nakhaei-Nejad M, Karthivashan G, Dorosh L, Amidian S, Dahal A, Li X, Stepanova M, Wille H, Giuliani F, Kar S. Bioact Mater 17 506-525 (2022)
  194. Simple, Reliable Protocol for High-Yield Solubilization of Seedless Amyloid-β Monomer. Taylor AIP, Davis PJ, Aubrey LD, White JBR, Parton ZN, Staniforth RA. ACS Chem Neurosci 14 53-71 (2023)
  195. Small-angle X-ray scattering characterization of a [Formula: see text]-amyloid model in phantoms. Breedlove S, Crentsil J, Dahal E, Badano A. BMC Res Notes 13 128 (2020)
  196. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression. De S, Whiten DR, Ruggeri FS, Hughes C, Rodrigues M, Sideris DI, Taylor CG, Aprile FA, Muyldermans S, Knowles TPJ, Vendruscolo M, Bryant C, Blennow K, Skoog I, Kern S, Zetterberg H, Klenerman D. Acta Neuropathol Commun 7 120 (2019)
  197. Spin Label Scanning Reveals Likely Locations of β-Strands in the Amyloid Fibrils of the Ure2 Prion Domain. Wang J, Park G, Lee YK, Nguyen M, San Fung T, Lin TY, Hsu F, Guo Z. ACS Omega 5 5984-5993 (2020)
  198. Sterol-activated amyloid beta fibril formation. Cook I, Leyh TS. J Biol Chem 299 105445 (2023)
  199. Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents. Perov S, Lidor O, Salinas N, Golan N, Tayeb-Fligelman E, Deshmukh M, Willbold D, Landau M. PLoS Pathog. 15 e1007978 (2019)
  200. Structural basis of FPR2 in recognition of Aβ42 and neuroprotection by humanin. Zhu Y, Lin X, Zong X, Han S, Wang M, Su Y, Ma L, Chu X, Yi C, Zhao Q, Wu B. Nat Commun 13 1775 (2022)
  201. Structure of amyloid-β (20-34) with Alzheimer's-associated isomerization at Asp23 reveals a distinct protofilament interface. Warmack RA, Boyer DR, Zee CT, Richards LS, Sawaya MR, Cascio D, Gonen T, Eisenberg DS, Clarke SG. Nat Commun 10 3357 (2019)
  202. The Amyloid Region of Hfq Riboregulator Promotes DsrA:rpoS RNAs Annealing. Turbant F, Wu P, Wien F, Arluison V. Biology (Basel) 10 900 (2021)
  203. The Route from the Folded to the Amyloid State: Exploring the Potential Energy Surface of a Drug-Like Miniprotein. Taricska N, Horváth D, Menyhárd DK, Ákontz-Kiss H, Noji M, So M, Goto Y, Fujiwara T, Perczel A. Chemistry 26 1968-1978 (2020)
  204. The amyloid concentric β-barrel hypothesis: Models of amyloid beta 42 oligomers and annular protofibrils. Durell SR, Kayed R, Guy HR. Proteins 90 1190-1209 (2022)
  205. The amyloid concentric β-barrel hypothesis: Models of synuclein oligomers, annular protofibrils, lipoproteins, and transmembrane channels. Durell SR, Guy HR. Proteins 90 512-542 (2022)
  206. Thermodynamic phase diagram of amyloid-β (16-22) peptide. Wang Y, Bunce SJ, Radford SE, Wilson AJ, Auer S, Hall CK. Proc. Natl. Acad. Sci. U.S.A. 116 2091-2096 (2019)
  207. Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State. Rodriguez RA, Chen LY, Plascencia-Villa G, Perry G. ACS Chem Neurosci 9 783-789 (2018)
  208. Total chemical synthesis and biophysical properties of a designed soluble 24 kDa amyloid analogue. Boehringer R, Kieffer B, Torbeev V. Chem Sci 9 5594-5599 (2018)
  209. Transcriptome driven discovery of novel candidate genes for human neurological disorders in the telomer-to-telomer genome assembly era. Falker-Gieske C. Hum Genomics 17 94 (2023)
  210. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. Guerrero-Ferreira R, Taylor NM, Arteni AA, Kumari P, Mona D, Ringler P, Britschgi M, Lauer ME, Makky A, Verasdonck J, Riek R, Melki R, Meier BH, Böckmann A, Bousset L, Stahlberg H. Elife 8 (2019)
  211. Virtual Quasi-2D Intermediates as Building Blocks for Plausible Structural Models of Amyloid Fibrils from Proteins with Complex Topologies: A Case Study of Insulin. Puławski W, Dzwolak W. Langmuir 38 7024-7034 (2022)
  212. X-ray Crystallography Reveals Parallel and Antiparallel β-Sheet Dimers of a β-Hairpin Derived from Aβ16-36 that Assemble to Form Different Tetramers. Kreutzer AG, Samdin TD, Guaglianone G, Spencer RK, Nowick JS. ACS Chem Neurosci 11 2340-2347 (2020)
  213. αB-Crystallin Chaperone Inhibits Aβ Aggregation by Capping the β-Sheet-Rich Oligomers and Fibrils. Sun Y, Ding F. J Phys Chem B 124 10138-10146 (2020)
  214. β-Sheet Structure within the Extracellular Domain of C99 Regulates Amyloidogenic Processing. Hu Y, Kienlen-Campard P, Tang TC, Perrin F, Opsomer R, Decock M, Pan X, Octave JN, Constantinescu SN, Smith SO. Sci Rep 7 17159 (2017)
  215. β-sheets in serum protein are independent risk factors for coronary lesions besides LDL-C in coronary heart disease patients. Li YL, Xie JY, Lu B, Sun XD, Chen FF, Tong ZJ, Sai WW, Zhang W, Wang ZH, Zhong M. Front Cardiovasc Med 9 911358 (2022)


Quick links